Sorting the Benign from the Lethal Headache
"Most headaches in the emergency department are benign, but a small number are the first and only warning of a catastrophe. The clinician's job is not to diagnose migraine — it is to identify the dangerous secondary headache hiding among the primary ones. The history that matters most is not the character of the pain, but its onset: the headache that reaches maximum intensity within seconds — the thunderclap — is subarachnoid haemorrhage until proven otherwise."
Tintinalli's Emergency Medicine, 9th Ed. Headache. McGraw-Hill; 2020.The dangerous secondary headaches
- Subarachnoid haemorrhage — thunderclap, "worst headache of my life", ± neck stiffness/LOC
- Meningitis / encephalitis — fever, neck stiffness, altered mentation, rash
- Cerebral venous sinus thrombosis — subacute, worse lying flat, seizures, risk factors (pregnancy, OCP, thrombophilia)
- Space-occupying lesion / raised ICP — progressive, worse in the morning/on Valsalva, papilloedema
- Giant cell (temporal) arteritis — age >50, jaw claudication, visual loss, tender temporal artery, high ESR/CRP
- Acute angle-closure glaucoma — painful red eye, halos, mid-dilated pupil
- Carbon monoxide poisoning — headache + multiple household members affected
- Arterial dissection (carotid/vertebral), pituitary apoplexy, pre-eclampsia/PRES
- Systemic symptoms/signs (fever, weight loss) · Neoplasm history · Neurological deficit or altered consciousness
- Onset sudden/thunderclap · Older age (>50 new headache) · Pattern change / Positional / Precipitated by Valsalva
- Papilloedema · Progressive · Pregnancy/puerperium · Painful eye · Post-traumatic · immunosuppression (HIV) · analgesic overuse
Why Aneurysmal SAH Kills in Two Waves
"Aneurysmal subarachnoid haemorrhage kills in two waves. The first is the ictus itself — the sudden rise in intracranial pressure and the risk of early rebleeding, which is lethal and most likely in the first 24–72 hours until the aneurysm is secured. The second wave comes days later: delayed cerebral ischaemia from vasospasm, the reason these patients stay in neurocritical care long after the bleed has stopped."
Rosen's Emergency Medicine, 10th Ed & Neurocritical Care Society guidance on aneurysmal SAH.- Rebleeding is most frequent in the first 24 hours and carries very high mortality — this is why the aneurysm is secured (coiling/clipping) as early as possible, and why blood pressure is controlled before it is secured.
- Delayed cerebral ischaemia (DCI) from vasospasm peaks days 4–14; nimodipine improves neurological outcome (though it does not reliably reverse angiographic spasm). Maintain euvolaemia — old "triple-H" therapy is out; treat DCI with induced hypertension and, if needed, endovascular therapy.
- Systemic effects: acute hydrocephalus (may need an EVD), seizures, hyponatraemia (cerebral salt wasting or SIADH — do not fluid-restrict CSW), neurogenic pulmonary oedema, and stress ("stunned") cardiomyopathy with troponin rise and ECG changes mimicking ACS.
- WFNS / Hunt & Hess — clinical grade (conscious level ± deficit); higher grade = worse prognosis.
- Modified Fisher — the amount and distribution of subarachnoid blood on CT predicts vasospasm/DCI risk.
Diagnosis & Acute Management
After 6 hours (or if any doubt): CT then lumbar puncture, looking for xanthochromia (spectrophotometry ideal; RBCs that do not clear tube-to-tube) — perform the LP ≥6–12 h after onset to allow xanthochromia to develop. CT angiography is an alternative pathway in some settings.
The Ottawa SAH Rule identifies alert patients ≥15 y with acute non-traumatic headache who need investigation (age ≥40, neck pain/stiffness, witnessed LOC, exertional onset, thunderclap/instant peak, limited neck flexion) — highly sensitive to select who to work up.
Until secured, control blood pressure (commonly SBP <~160 mmHg — balance rebleed vs perfusion) with a titratable agent, provide analgesia, and manage acute hydrocephalus with an external ventricular drain if needed. A short course of an antifibrinolytic may be considered pre-securing in selected cases.
Maintain euvolaemia (not prophylactic hypervolaemia/"triple-H"). Monitor for DCI clinically ± transcranial Doppler/CT perfusion; treat established DCI with induced hypertension and consider endovascular therapy (angioplasty/intra-arterial vasodilators).
Access to 24/7 neurointervention and neurosurgery is concentrated in tertiary centres — recognise SAH early and transfer promptly, controlling BP and pain en route. Nimodipine is widely available and inexpensive; start it as soon as SAH is confirmed.
Remember the endemic mimics of "headache + fever + neck stiffness": tuberculous and pyogenic meningitis, cerebral malaria, dengue, scrub typhus and neurocysticercosis. A febrile thunderclap still needs SAH excluded, but the differential is broader in India.
Drug Reference — SAH / Dangerous Headache
| Drug | Indication | Dose | Notes |
|---|---|---|---|
| Nimodipine | aSAH — prevent DCI | 60 mg PO/NG every 4 h for 21 days | Improves outcome; if hypotensive give 30 mg 2-hourly rather than stopping; support BP |
| Labetalol / nicardipine / esmolol | BP control before aneurysm secured | Titrate (e.g. SBP <~160) | Use short-acting titratable agents; avoid precipitous drops |
| Tranexamic acid | Short-term antifibrinolysis pre-securing (selected) | Per protocol, short course | Consider only until aneurysm secured; balance rebleed vs ischaemia/DVT |
| Analgesia (paracetamol ± opioid) | Pain (reduces BP surges) | Titrated | Control pain and agitation to limit rebleed risk |
| Levetiracetam | Seizure (if occurs) | Per protocol | Treat seizures; routine prophylaxis not universally recommended |
| Hypertonic saline | Symptomatic hyponatraemia / raised ICP | Per protocol | CSW is common — do not fluid-restrict; maintain euvolaemia/Na⁺ |
| Ceftriaxone + vancomycin (± aciclovir) | If meningitis/encephalitis suspected | Empirical, weight/renal-adjusted | Do not delay antibiotics for imaging/LP when meningitis is likely |
| High-dose steroids | Suspected giant cell arteritis | Prednisolone 40–60 mg (IV methylpred if visual loss) | Start immediately to save vision; then confirm (ESR/CRP, biopsy) |
Acute Severe Headache Pathway
Screen for red flags
- Thunderclap/instant-peak onset, worst-ever, neurological deficit, altered mentation
- Fever + meningism, papilloedema, age >50 new headache, positional, pregnancy, painful red eye
- Resuscitate and give empirical antibiotics ± aciclovir immediately if meningitis/encephalitis likely
Exclude SAH
- Non-contrast CT head <6 h from onset → >98–99% sensitive; normal ⇒ SAH effectively excluded (intact patient)
- >6 h or doubt → CT + LP for xanthochromia (LP ≥6–12 h after onset), or CTA per local pathway
SAH confirmed — stabilise & grade
- Control BP (SBP <~160), analgesia, EVD if hydrocephalus; grade (WFNS/Hunt-Hess, modified Fisher)
- Urgent neurosurgery/neurointervention referral; start nimodipine
Secure the aneurysm
- Coiling or clipping within 24–72 h (coiling preferred if amenable — ISAT) to prevent rebleeding
Neurocritical care — watch for DCI
- Continue nimodipine 21 days; maintain euvolaemia; monitor for vasospasm/DCI (days 4–14)
- Treat DCI with induced hypertension ± endovascular therapy; manage hyponatraemia (CSW — don't restrict), seizures, cardiac stunning
Common Mistakes in Headache / SAH
A headache reaching maximum intensity within seconds is SAH until excluded — even if it later eases with analgesia. Response to a "migraine cocktail" does not rule out SAH.
CT sensitivity for SAH falls after 6 hours. Beyond that window, a normal CT must be followed by LP for xanthochromia (or a defined CTA pathway) — don't discharge on a late-normal CT alone.
Xanthochromia takes several hours to develop; an LP done before ~6–12 h after onset may miss it, and a traumatic tap can confuse interpretation. Time the LP and look for a non-clearing RBC count plus xanthochromia.
Cerebral salt wasting causes hypovolaemic hyponatraemia; restricting fluids worsens hypovolaemia and DCI risk. Maintain euvolaemia and replace sodium (hypertonic saline if needed).
Nimodipine improves outcome and should be continued for 21 days. If it lowers BP, reduce the dose/frequency and support the pressure rather than discontinuing it.
When bacterial meningitis is likely, give antibiotics (± aciclovir) immediately — do not wait for CT/LP. When giant cell arteritis threatens vision, start high-dose steroids before biopsy.
SAH causes neurogenic stress cardiomyopathy with troponin rise, ECG changes and pulmonary oedema. Anticoagulating/thrombolysing this "ACS" would be catastrophic — the brain is the primary problem.
Exam Pearls
Q: What is a thunderclap headache, and what must be excluded?
A headache reaching maximum intensity within seconds to a minute. It is subarachnoid haemorrhage until proven otherwise (also consider CVST, dissection, RCVS, pituitary apoplexy).
Q: How sensitive is CT for SAH, and how does timing matter?
Non-contrast CT within 6 hours of onset is >98–99% sensitive; sensitivity declines afterwards, mandating CT + LP (or CTA) beyond that window.
Q: What are you looking for on LP, and when should it be done?
Xanthochromia (and a non-clearing RBC count), best assessed ≥6–12 h after headache onset to allow it to develop.
Q: When and how is the aneurysm secured?
Early (within 24–72 h) by coiling or clipping to prevent rebleeding; endovascular coiling is preferred where feasible (ISAT).
Q: What is the role of nimodipine?
Oral nimodipine 60 mg 4-hourly for 21 days improves neurological outcome in aSAH by reducing delayed cerebral ischaemia (it does not reliably reverse angiographic vasospasm).
Q: How is delayed cerebral ischaemia managed today?
Maintain euvolaemia (not prophylactic triple-H), monitor days 4–14, and treat established DCI with induced hypertension ± endovascular angioplasty/vasodilators.
Q: Why can SAH mimic an MI?
It causes neurogenic stress (stunned) cardiomyopathy with troponin rise, ECG changes and neurogenic pulmonary oedema — the primary pathology is intracranial.
Q: Name the grading scales used in aSAH.
Clinical: WFNS and Hunt & Hess. Radiological (vasospasm risk): modified Fisher scale.
References
- Hoh BL, Ko NU, Amin-Hanjani S, et al. (AHA/ASA). 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2023;54:e314–e370.
- Perry JJ, Stiell IG, Sivilotti MLA, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache (Ottawa SAH Rule). JAMA. 2013;310:1248–1255.
- Perry JJ, Stiell IG, Sivilotti MLA, et al. Sensitivity of CT performed within six hours of onset of headache for diagnosis of SAH. BMJ. 2011;343:d4277.
- Molyneux A, Kerr R, et al. (ISAT). International Subarachnoid Aneurysm Trial: coiling versus clipping. Lancet. 2002;360:1267–1274.
- Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches (SNNOOP10 list). Neurology. 2019;92:134–144.
- Tintinalli JE, et al. Tintinalli's Emergency Medicine, 9th Edition. Headache. McGraw-Hill; 2020.
- Connolly ES, Rabinstein AA, et al. (AHA/ASA). Guidelines for the Management of Aneurysmal SAH (prior edition). Stroke. 2012;43:1711–1737.